Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Armata Pharmaceuticals (ARMP) Profit After Tax (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Profit After Tax for 6 consecutive years, with -$1.1 million as the latest value for Q4 2018.

  • Quarterly Profit After Tax rose 53.19% to -$1.1 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was -$10.2 million through Dec 2018, up 20.76% year-over-year, with the annual reading at -$173.8 million for FY2025, 818.79% down from the prior year.
  • Profit After Tax hit -$1.1 million in Q4 2018 for Armata Pharmaceuticals, up from -$2.8 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $21.2 million in Q3 2014 to a low of -$14.5 million in Q1 2015.
  • Historically, Profit After Tax has averaged -$962800.0 across 5 years, with a median of -$2.6 million in 2016.
  • Biggest YoY gain for Profit After Tax was 194.74% in 2014; the steepest drop was 587.36% in 2014.
  • Year by year, Profit After Tax stood at -$664000.0 in 2014, then plummeted by 235.99% to -$2.2 million in 2015, then crashed by 325.82% to -$9.5 million in 2016, then soared by 75.24% to -$2.4 million in 2017, then skyrocketed by 53.19% to -$1.1 million in 2018.
  • Business Quant data shows Profit After Tax for ARMP at -$1.1 million in Q4 2018, -$2.8 million in Q3 2018, and -$3.2 million in Q2 2018.